MyMD Pharmaceuticals (MYMD) Insider Trading & Ownership $0.13 +0.02 (+17.75%) As of 07/24/2025 Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsFDA EventsInsider TradesOptions ChainSEC FilingsTrendsBuy This Stock MyMD Pharmaceuticals (NASDAQ:MYMD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.12%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$181.78KNumber OfInsiders Selling(Last 3 Years)0 Get MYMD Insider Trade Alerts Want to know when executives and insiders are buying or selling MyMD Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MYMD Insider Buying and Selling by Quarter MyMD Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/24/2023Paul RivardInsiderBuy5,000$33.30$166,500.00 12/8/2022Paul RivardEVPBuy333$45.90$15,284.70 (Data available from 1/1/2013 forward) MYMD Insider Trading Activity - Frequently Asked Questions Who is on MyMD Pharmaceuticals' Insider Roster? The list of insiders at MyMD Pharmaceuticals includes Paul Rivard. Learn more on insiders at MYMD. What percentage of MyMD Pharmaceuticals stock is owned by insiders? 2.12% of MyMD Pharmaceuticals stock is owned by insiders. Learn more on MYMD's insider holdings. Which MyMD Pharmaceuticals insiders have been buying company stock? The following insider purchased MYMD shares in the last 24 months: Paul Rivard ($166,500.00). How much insider buying is happening at MyMD Pharmaceuticals? Insiders have purchased a total of 5,000 MYMD shares in the last 24 months for a total of $166,500.00 bought. MyMD Pharmaceuticals Key ExecutivesDr. Christopher C. Chapman Jr. (Age 71)M.D., President, Chief Medical Officer & Director Compensation: $665.76kMr. Ian Rhodes CPA (Age 51)Interim Chief Financial Officer Compensation: $162kDr. Jenna Brager M.S.Ph.D., R.N., Executive Vice President of Drug Development More Insider Trading Tools from MarketBeat Related Companies PBLA Insider Selling HEPA Insider Selling SYRS Insider Selling VIRX Insider Selling VINC Insider Selling SMFL Insider Selling VAXX Insider Selling EVLO Insider Selling CMRA Insider Selling AMPE Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:MYMD) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyMD Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MyMD Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
